News
Certest Pharma participates in RNA Leaders USA
Certest Pharma is dedicated to building a platform for the development of RNA vaccines, with a special focus on seeking improved formulations to enhance delivery. In that sense, Certest Pharma [...]
STABVAC4COV Project
Certest faces the final phase of the project “Development of mRNA thermostable vaccines against SARS-COV-2 Delta variant”, which runs from January 2021 to December 2023. Animal challenge studies are currently [...]
FANZOR: The eukaryotic CRISPR
Spanish researcher Francis Mojica accidentally discovered that certain microbes from the salt flats in Alicante use molecular scissors called CRISPR to eliminate invading viruses. Later, J. Doudna and E. Charpentier [...]
TIDES USA 2023
Certest Pharma present at TIDES USA 2023. From May 7th to 10th, the TIDES Oligonucleotide & Peptide Therapeutics conference took place in San Diego, USA. It is considered the largest [...]
World Vaccine Congress Barcelona 2022
The World Vaccine Congress arrives in Barcelona on October 12, 13 and 14, becoming the largest and most important meeting point in the world on vaccines and manufacturing technology and [...]
BIO International Convention 2022
CerTest VACCINES will be present next June 13 to 16 at the BIO International Convention 2022, which will be held at the San Diego Convention Center, USA. BIO is [...]
9th International mRNA Health Conference.
CerTest VACCINES will be present for the first time at this evento, with the aim of showing the company’s potential to provide new solutions that can help facing future situations [...]
2021 AACC Exhibition
After the stoppage in the 2020 edition forced by the pandemic, the AACC Exhibition returns in a live event which will be held in Atlanta, United States, from September [...]
MEDICA 2021
After the absence in 2020 forced by the pandemic, this year MEDICA returns to its face-to-face format, from November 15 to 18, at Düsseldorf. Certest Pharma, the new division [...]
